Derved mindskes hyppigheden, sværheden og varigheden af mucositis i munden hos kræftpatienter, der får intensiv behandling.
Kepivance stimulates the growth of these cells, helping to reduce the incidence, severity and duration of oral mucositis in cancer patients undergoing intensive therapy.